EUVIMEDEUVIMED entdecken
Open Access

Synovial 5‐Lipoxygenase–Derived Oxylipins Define a Lympho‐Myeloid–Enriched Synovium

Jessica D Murillo-Saich iD, Roxana Coras, Julio Ramirez iD, Estefania Quesada-Masachs iD, Marta Sala-Climent, Katharina Eschelbach, Christopher B Mahony iD, Raquel Celis, Aaron Armando, Oswald Quehenberger, Adam P Croft iD, Arthur Kavanaugh und 4 weitere

Arthritis & Rheumatology · 2024

DOI: 10.1002/art.42848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2024. Verfasst von Jessica D Murillo-Saich und 15 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Diego. Hauptthemen laut MEDLINE: Synovial Membrane, Oxylipins, Arthritis, Rheumatoid, Arachidonate 5-Lipoxygenase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Kennedy Trust for Rheumatology Research Senior Fellowship, Fundación Española de Reumatología, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Oxylipins are bioactive lipids derived from polyunsaturated fatty acids (PUFAs) that modulate inflammation and may remain overexpressed in refractory synovitis. In plasma, they could also be biomarkers of synovial pathology. The aim of this study is to determine if synovial oxylipins in inflamed joints correlate with plasma oxylipins and with synovial histologic patterns.

Methods

Patients with established rheumatoid or psoriatic arthritis with active disease despite treatment were recruited, and paired synovial tissue (ST) and plasma were collected. Oxylipins were determined by liquid chromatography with tandem mass spectrometry and were classified into groups according to their PUFA precursor and enzyme. The expression of CD20, CD68, CD3, and CD138 was obtained to describe synovial histology. Cell‐specific expression of oxylipin‐related genes was identified by examining available synovial single‐cell RNA sequencing data.

Results

We included a total of 32 ST and 26 paired‐plasma samples. A total of 71 oxylipins were identified in ST, but only 24 were identified in plasma. Only levels of 9,10‐dihydroxyoctadecenoic acid and tetranor‐Prostaglandin FM had a significant positive correlation between plasma and ST. Several oxylipins and oxylipin‐related genes were differentially expressed among synovial phenotypes. Specifically, several 5‐lipoxygenase (LOX)–derived oxylipins were statistically elevated in the lympho‐myeloid phenotype and associated with B cell expression in rheumatoid arthritis samples.

Conclusion

The lack of correlation between ST and plasma oxylipins suggests that ST lipid profiling better characterizes active pathways in treated joints. Synovial 5‐LOX–derived oxylipins were highly expressed in lympho‐myeloid–enriched synovium. Combination therapy with 5‐LOX inhibitors to improve refractory inflammation may be needed in patients with this histologic group. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Synovial MembraneOxylipinsArthritis, RheumatoidArachidonate 5-LipoxygenaseArthritis, PsoriaticHumansMiddle AgedMaleFemaleFatty Acids, UnsaturatedAgedAdultBiomarkers

Substanzen

OxylipinsArachidonate 5-LipoxygenaseFatty Acids, UnsaturatedBiomarkers

Autor:innen und Institutionen

  • University of California, San Diego.
  • Hospital Clinic and Instituto de Investigaciones Biomédicas August Pi i Sunyer, Barcelona, Spain.
  • La Jolla Institute for Immunology, San Diego, California.
  • Queen Elizabeth Hospital and University of Birmingham, Birmingham, United Kingdom.
  • University of California, San Diego, and Veterans Affairs San Diego Healthcare System.

ORCID-Profile: Jessica D Murillo-Saich, Julio Ramirez, Estefania Quesada-Masachs, Christopher B Mahony, Adam P Croft, Juan D Cañete, Monica Guma

Förderung

  • Kennedy Trust for Rheumatology Research Senior Fellowship
  • Fundación Española de Reumatología
  • NIAMS NIH HHS
  • Novartis
  • NIH HHS
  • Pfizer
  • Foundation for Rheumatology Research Career Grant
  • NIH

Zitieren

APA

Murillo-Saich, J. D., Coras, R., Ramirez, J., Quesada-Masachs, E., Sala-Climent, M., Eschelbach, K., Mahony, C. B., Celis, R., Armando, A., Quehenberger, O., Croft, A. P., Kavanaugh, A., Chang, E., Cañete, J. D., Singh, A., & Guma, M. (2024). Synovial 5‐Lipoxygenase–Derived Oxylipins Define a Lympho‐Myeloid–Enriched Synovium. Arthritis & Rheumatology. https://doi.org/10.1002/art.42848

Vancouver

Murillo-Saich JD, Coras R, Ramirez J, Quesada-Masachs E, Sala-Climent M, Eschelbach K, et al. Synovial 5‐Lipoxygenase–Derived Oxylipins Define a Lympho‐Myeloid–Enriched Synovium. Arthritis & Rheumatology. 2024. doi:10.1002/art.42848

BibTeX
@article{MurilloSaich2024,
  author = {Murillo-Saich, Jessica D and Coras, Roxana and Ramirez, Julio and Quesada-Masachs, Estefania and Sala-Climent, Marta and Eschelbach, Katharina and Mahony, Christopher B and Celis, Raquel and Armando, Aaron and Quehenberger, Oswald and Croft, Adam P and Kavanaugh, Arthur and Chang, Eric and Cañete, Juan D and Singh, Abha and Guma, Monica},
  title = {Synovial 5‐Lipoxygenase–Derived Oxylipins Define a Lympho‐Myeloid–Enriched Synovium},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  doi = {10.1002/art.42848}
}
Kostenlos starten →